drugset / Trial / NCT02742532
Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
Phase 2
Completed
63 enrolled
Jennifer Mitchell
Congressionally Directed Medical Research Programs · collabEisenhower Army Medical Center · collabUnited States Department of Defense · collabUnited States Naval Medical Center, San Diego · collab
RandomizedParallel-groupTriple-blindBasic science
Summary
The purpose of this study is to determine whether oxytocin will decrease craving to use drugs/alcohol and stress reactivity following exposure to laboratory-induced stress among Active Duty Service Members with a dual diagnosis of alcohol/substance use disorder (ASUD) and post-traumatic anxiety.
Timeline
- Start
- 2017-04-20
- Primary completion
- 2019-07-01
- Completion
- 2019-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 40 iu | Other |